ABSTRACT During visceral leishmaniasis, the control of hepatic parasite burden is mainly due to granuloma assembly in a mi-croenvironment consisting of both Th1 and Th2 components. Using enzyme-linked immunosorbent assay (ELISA) dosages, quantitative PCR (qPCR), immunohistochemistry, and flow cytometry, we studied the role of interleukin-33 (IL-33), a recently described cytokine signaling through the ST2 receptor, during visceral leishmaniasis. We showed that a higher level of IL-33 was detected in the serum of patients with visceral leishmaniasis than in that from healthy donors and demonstrated the presence of IL-33 cells in a liver biopsy specimen from a patient. Similarly, in BALB/c mice experimentally infected with L. donovani, a high...
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is...
Interleukin-32 (IL-32) is expressed in lesions of patients with American Tegumentary Leishmaniasis (...
Contains fulltext : 169942.pdf (publisher's version ) (Open Access)BACKGROUND: Int...
ABSTRACT During visceral leishmaniasis, the control of hepatic parasite burden is mainly due to gran...
ABSTRACT During visceral leishmaniasis, the control of hepatic parasite burden is mainly due to gran...
International audienceUNLABELLED: During visceral leishmaniasis, the control of hepatic parasite bur...
Visceral leishmaniasis is a life-threatening systemic disease caused by Leishmania protozoans, L. do...
La leishmaniose viscérale est une maladie systémique mortelle en l’absence de traitement. Elle est d...
International audienceBackground: During infection with Leishmania donovani, parasite control is lin...
Previous studies comparing interleukin 4 receptor a (IL-4Ra)-/- and interleukin 4 (IL-4)-/- BALB/c m...
<div><p>Background</p><p>Interleukin-32 (IL-32) is expressed in lesions of patients with American Te...
Previous studies comparing interleukin 4 receptor alpha (IL-4R alpha)(-/-) and interleukin 4 (IL-4)(...
Control of visceral leishmaniasis (VL) caused by Leishmania donovani requires interferon-γproduction...
Visceral leishmaniasis (VL), caused by infection with the intracellular protozoan Leishmania donovan...
In experimental visceral leishmaniasis, interleukin (IL)±12 initiates control over Leishmania donova...
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is...
Interleukin-32 (IL-32) is expressed in lesions of patients with American Tegumentary Leishmaniasis (...
Contains fulltext : 169942.pdf (publisher's version ) (Open Access)BACKGROUND: Int...
ABSTRACT During visceral leishmaniasis, the control of hepatic parasite burden is mainly due to gran...
ABSTRACT During visceral leishmaniasis, the control of hepatic parasite burden is mainly due to gran...
International audienceUNLABELLED: During visceral leishmaniasis, the control of hepatic parasite bur...
Visceral leishmaniasis is a life-threatening systemic disease caused by Leishmania protozoans, L. do...
La leishmaniose viscérale est une maladie systémique mortelle en l’absence de traitement. Elle est d...
International audienceBackground: During infection with Leishmania donovani, parasite control is lin...
Previous studies comparing interleukin 4 receptor a (IL-4Ra)-/- and interleukin 4 (IL-4)-/- BALB/c m...
<div><p>Background</p><p>Interleukin-32 (IL-32) is expressed in lesions of patients with American Te...
Previous studies comparing interleukin 4 receptor alpha (IL-4R alpha)(-/-) and interleukin 4 (IL-4)(...
Control of visceral leishmaniasis (VL) caused by Leishmania donovani requires interferon-γproduction...
Visceral leishmaniasis (VL), caused by infection with the intracellular protozoan Leishmania donovan...
In experimental visceral leishmaniasis, interleukin (IL)±12 initiates control over Leishmania donova...
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is...
Interleukin-32 (IL-32) is expressed in lesions of patients with American Tegumentary Leishmaniasis (...
Contains fulltext : 169942.pdf (publisher's version ) (Open Access)BACKGROUND: Int...